Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | 1H-Imidazole,2,5-dibromo-4-(trifluoromethyl)- REF: IN-DA005848CAS: 81654-02-6 | 98% | 181.00 € | Mon 03 Mar 25 |
![]() | 2,4-Dibromo-5-(trifluoromethyl)-1H-imidazole REF: 54-PC9738CAS: 81654-02-6 | 97% | 344.00 €~1,051.00 € | Tue 04 Mar 25 |
![]() | 2,4-DIBROMO-5-(TRIFLUOROMETHYL)-1H-IMIDAZOLE REF: 10-F468937CAS: 81654-02-6 | 95.0% | To inquire | Thu 13 Mar 25 |
![]() | 2,4-Dibromo-5-(trifluoromethyl)-1H-imidazole REF: 3D-FD147690CAS: 81654-02-6 | Min. 95% | - - - | Discontinued product |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
1H-Imidazole,2,5-dibromo-4-(trifluoromethyl)-
CAS:81654-02-6
Formula:
C4HBr2F3N2
Purity:
98%
Molecular weight:
293.8673
Ref: IN-DA005848
100mg | 181.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
2,4-Dibromo-5-(trifluoromethyl)-1H-imidazole
CAS:81654-02-6
Purity:
97%
Color and Shape:
Solid
Molecular weight:
293.87g/mol
Ref: 54-PC9738
1g | 344.00 € | ||
5g | 1,051.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
2,4-DIBROMO-5-(TRIFLUOROMETHYL)-1H-IMIDAZOLE
CAS:81654-02-6
Purity:
95.0%
Color and Shape:
Solid
Molecular weight:
293.8689880371094
Ref: 10-F468937
100mg | To inquire |
Estimated delivery in United States, on Thursday 13 Mar 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
2,4-Dibromo-5-(trifluoromethyl)-1H-imidazole
CAS:81654-02-6
Please enquire for more information about 2,4-Dibromo-5-(trifluoromethyl)-1H-imidazole including the price, delivery time and more detailed …
Formula:
C4HBr2F3N2
Purity:
Min. 95%
Molecular weight:
293.87 g/mol
Ref: 3D-FD147690
1g | Discontinued | Request information | |
2g | Discontinued | Request information | |
5g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |